Evidence map›Paper›PMID 27920671›Full record

ArticleFrontiers in integrative neuroscience2016

Proceedings of the Fourth Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and Technologies.

Wissam Deeb, James J Giordano, Peter J Rossi, Alon Y Mogilner, Aysegul Gunduz, Jack W Judy, Bryan T Klassen, Christopher R Butson, Craig Van Horne, Damiaan Deny and 27 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in integrative neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Deep brain stimulation for Parkinson's disease.Journal of internal medicine · 2022
    Review
  9. Article
  10. Review
  11. Article
  12. Peripheral Neuromodulation for the Management of Headache.Anesthesiology and pain medicine · 2020
    Review
  13. Review
  14. Article
  15. Article
  16. Neuroethics of Neuromodulation: An Update.Current opinion in biomedical engineering · 2018
    Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Wissam DeebDepartment of Neurology, Center for Movement Disorders and Neurorestoration, University of Florida Gainesville, FL, USA.
James J GiordanoDepartment of Neurology, and Neuroethics Studies Program, Pellegrino Center for Clinical Bioethics, Georgetown University Medical Center Washington, DC, USA.
Peter J RossiDepartment of Neurology, Center for Movement Disorders and Neurorestoration, University of Florida Gainesville, FL, USA.
Alon Y MogilnerDepartment of Neurosurgery, Center for Neuromodulation, New York University Langone Medical Center New York, NY, USA.
Aysegul GunduzDepartment of Neurology, Center for Movement Disorders and Neurorestoration, University of FloridaGainesville, FL, USA; J. Crayton Pruitt Family Department of Biomedical Engineering, University of FloridaGainesville, FL, USA.
Jack W JudyDepartment of Neurology, Center for Movement Disorders and Neurorestoration, University of FloridaGainesville, FL, USA; J. Crayton Pruitt Family Department of Biomedical Engineering, University of FloridaGainesville, FL, USA.
Bryan T KlassenDepartment of Neurology, Mayo Clinic Rochester, MN, USA.
Christopher R ButsonDepartment of Bioengineering, Scientific Computing and Imaging Institute, University of Utah Salt Lake City, UT, USA.
Craig Van HorneDepartment of Neurosurgery, University of Kentucky Chandler Medical Center Lexington, KY, USA.
Damiaan DenyDepartment of Psychiatry, Academic Medical Center, University of Amsterdam Amsterdam, Netherlands.
Darin D DoughertyDepartment of Psychiatry, Massachusetts General Hospital Boston, MA, USA.
David RowellAsia Pacific Centre for Neuromodulation, Queensland Brain Institute, The University of Queensland Brisbane, QLD, Australia.
Greg A GerhardtDepartment of Anatomy and Neurobiology, University of Kentucky Chandler Medical Center Lexington, KY, USA.
Gwenn S SmithDepartments of Psychiatry and Behavioral Sciences and Radiology and Radiological Sciences, Johns Hopkins University School of Medicine Baltimore, MD, USA.
Francisco A PonceDivision of Neurological Surgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center Phoenix Arizona, AZ, USA.
Harrison C WalkerDepartment of Neurology and Department of Biomedical Engineering, University of Alabama at Birmingham Birmingham, AL, USA.
Helen M Bronte-StewartDepartments of Neurology and Neurological Sciences and Neurosurgery, Stanford University Stanford, CA, USA.
Helen S MaybergDepartment of Psychiatry, Emory University School of Medicine Atlanta, GA, USA.
Howard J ChizeckElectrical Engineering Department, University of WashingtonSeattle, WA, USA; NSF Engineering Research Center for Sensorimotor Neural EngineeringSeattle, WA, USA.
Jean-Philippe LangevinDepartment of Neurosurgery, VA Greater Los Angeles Healthcare System Los Angeles, CA, USA.
Jens VolkmannDepartment of Neurology, University Clinic of Würzburg Würzburg, Germany.
Jill L OstremDepartment of Neurology, University of California San Francisco San Francisco, CA, USA.
Jonathan B ShuteJ. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida Gainesville, FL, USA.
Joohi Jimenez-ShahedDepartment of Neurology, Baylor College of Medicine Houston, TX, USA.
Kelly D FooteDepartment of Neurology, Center for Movement Disorders and Neurorestoration, University of FloridaGainesville, FL, USA; Department of Neurological Sciences, University of FloridaGainesville, FL, USA.
Aparna Wagle ShuklaDepartment of Neurology, Center for Movement Disorders and Neurorestoration, University of Florida Gainesville, FL, USA.
Marvin A RossiDepartments of Neurological Sciences, Diagnostic Radiology, and Nuclear Medicine, Rush University Medical Center Chicago, IL, USA.
Michael OhDivision of Functional Neurosurgery, Department of Neurosurgery, Allegheny General Hospital Pittsburgh, PA, USA.
Michael PourfarDepartment of Neurology, New York University Langone Medical Center New York, NY, USA.
Paul B RosenbergPsychiatry and Behavioral Sciences, Johns Hopkins Bayview Medical Center, Johns Hopkins School of Medicine Baltimore, MD, USA.
Peter A SilburnAsia Pacific Centre for Neuromodulation, Queensland Brain Institute, The University of Queensland Brisbane, QLD, Australia.
Coralie de HemptineGraduate Program in Neuroscience, Department of Neurological Surgery, Kavli Institute for Fundamental Neuroscience, University of California, San Francisco San Francisco, CA, USA.
Philip A StarrGraduate Program in Neuroscience, Department of Neurological Surgery, Kavli Institute for Fundamental Neuroscience, University of California, San Francisco San Francisco, CA, USA.
Timothy DenisonMedtronic Modulation Minneapolis, MN, USA.
Umer AkbarMovement Disorders Program, Department of Neurology, Alpert Medical School, Rhode Island Hospital, Brown University Providence, RI, USA.
Warren M GrillDepartment of Biomedical Engineering, Duke University Durham, NC, USA.
Michael S OkunDepartment of Neurology, Center for Movement Disorders and Neurorestoration, University of Florida Gainesville, FL, USA.

Funding

'T V ASSESSMENT - MEMORY DISORDERED PATIENTS'P50AG005146 · NIA · JOHNS HOPKINS UNIVERSITY · PI ALBERT, MARILYN S. · 1985 to 2019
$37.6M
Noninvasive Biomarkers to Advance Emerging DBS Electrode Technologies in Parkinson's DiseaseUH3NS100553 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WALKER, HARRISON CARROLL · 2016 to 2021
$7.3M
Temporal Patterns of Deep Brain StimulationR37NS040894 · NINDS · DUKE UNIVERSITY · PI GRILL, WARREN M. · 2015 to 2021
$4.2M
THE HUMAN THALAMOCORTICAL NETWORK IN TOURETTE SYNDROMER01NS096008 · NINDS · UNIVERSITY OF FLORIDA · PI GUNDUZ, AYSEGUL, OKUN, MICHAEL S · 2016 to 2020
$1.8M
Recording Evoked Potentials for Closed-Loop DBSR01NS079312 · NINDS · DUKE UNIVERSITY · PI GRILL, WARREN M. · 2012 to 2014
$1.1M
NIA NIH HHS P50 AG005146NINDS NIH HHS R01 NS079312NINDS NIH HHS R01 NS096008NINDS NIH HHS R37 NS040894NINDS NIH HHS UH3 NS100553
6 · The paper itself

Abstract

This paper provides an overview of current progress in the technological advances and the use of deep brain stimulation (DBS) to treat neurological and neuropsychiatric disorders, as presented by participants of the Fourth Annual DBS Think Tank, which was convened in March 2016 in conjunction with the Center for Movement Disorders and Neurorestoration at the University of Florida, Gainesveille FL, USA. The Think Tank discussions first focused on policy and advocacy in DBS research and clinical practice, formation of registries, and issues involving the use of DBS in the treatment of Tourette Syndrome. Next, advances in the use of neuroimaging and electrochemical markers to enhance DBS specificity were addressed. Updates on ongoing use and developments of DBS for the treatment of Parkinson's disease, essential tremor, Alzheimer's disease, depression, post-traumatic stress disorder, obesity, addiction were presented, and progress toward innovation(s) in closed-loop applications were discussed. Each section of these proceedings provides updates and highlights of new information as presented at this year's international Think Tank, with a view toward current and near future advancement of the field.

Indexed as

Alzheimer's diseaseclosed-loopDARPAdeep brain stimulationdepressionParkinson's diseasepost-traumatic stress disorderTourette syndrome

Identifiers

PMID27920671
PMCPMC5119052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.